Professional Continuous Glucose Monitoring at the Parkland Diabetes Clinic

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to assess whether the short-term use of professional continuous glucose monitoring (Pro-CGM) at the Parkland Diabetes Clinic in selected patients with poorly-controlled diabetes due to hyper- and/or hypoglycemia leads to improvements in patients' glycemic control within 3-6 months, subjective understanding of how food, activity, and medications affect blood sugar levels, and diabetes self-care practices. The study will be a prospective cohort study that assesses patients glycemic control and diabetes self-care practices before and 3-6 months after utilization of a Pro-CGM for 10 days. Glycemic control and diabetes self-care practices will be assessed based on hemoglobin A1c measurements and glucose data download from glucometer and Pro-CGM. A short survey will be administered at the end of the 10 days Pro-CGM use to assess whether the Pro-CGM use had a positive impact on patients' understanding of how different activities affect their blood sugar and diabetes self-care practices. Parkland Diabetes Clinic serves an ethnically diverse, low socioeconomic patient population, the majority of whom do not have access to diabetes technology like continuous glucose monitoring. CGM measures sugar levels every 5 to 15 minutes and have been shown in clinical studies to improve glycemic control. Establishing a professional CGM program at the clinic will provide short-term access to this technology. One of the main reason for conducting this study is to determine if Pro-CGM would be a useful intervention to integrate into the clinic's routine practice in the future.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05420714
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact
Status	Withdrawn
Phase	N/A
Start date	August 2022
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05563090` - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Recruiting	`NCT05333159` - The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
Active, not recruiting	`NCT03119584` - Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation	Phase 4
Completed	`NCT04409171` - Glucose Metabolism After Partial Pancreatectomy
Recruiting	`NCT06060392` - Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus	N/A
Completed	`NCT05144971` - StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
Completed	`NCT03914183` - Can mCPN Intervention Improve Injection Site Rotation	N/A
Completed	`NCT03781232` - Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes	N/A
Not yet recruiting	`NCT06150508` - Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health	N/A
Completed	`NCT01252810` - Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure	Phase 2
Active, not recruiting	`NCT04171557` - Bicycling and Mortality Among Individuals With diabetesNutrition (EPIC)
Active, not recruiting	`NCT03155594` - CGM to Aid Transition From Inpatient to Outpatient	N/A
Not yet recruiting	`NCT06358118` - Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders	N/A
Completed	`NCT04864327` - Smoking Intervention Among Patients With Diabetes	N/A
Completed	`NCT04407182` - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19	Phase 2
Completed	`NCT05752591` - Hypothalamic-pituitary Dysfunction in Diabetes
Completed	`NCT03159546` - FreeStyle Libre Flash Glucose Monitoring System Accuracy	N/A
Completed	`NCT03953092` - A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699	Phase 1
Not yet recruiting	`NCT06262854` - Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study	N/A
Completed	`NCT03934281` - Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient	N/A